Fig. 1From: The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificityAntibody responses stratified by protection status. Endpoint ELISA antibody titres are shown for recombinant full-length CS (a), NANP repeat peptide (b), and the C-terminal PF16 peptide (c) for non-protected (NP) and protected (P) individuals. p value determined using Student’s t testBack to article page